Verrica Pharmaceuticals (NASDAQ:VRCA – Get Free Report) and RenovoRx (NASDAQ:RNXT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, analyst recommendations and profitability. Earnings & Valuation This table compares Verrica Pharmaceuticals […]
Verrica Pharmaceuticals (NASDAQ:VRCA – Free Report) had its price target increased by HC Wainwright from $13.00 to $14.00 in a report released on Tuesday, Benzinga reports. They currently have a buy rating on the stock. Separately, Needham & Company LLC reiterated a buy rating and issued a $8.00 price objective on shares of Verrica Pharmaceuticals […]
Verrica Pharmaceuticals (NASDAQ:VRCA – Free Report) had its price target raised by Needham & Company LLC from $8.00 to $16.00 in a research note issued to investors on Tuesday morning, Benzinga reports. The firm currently has a buy rating on the stock. Separately, HC Wainwright boosted their target price on Verrica Pharmaceuticals from $13.00 to […]
Kornitzer Capital Management Inc. KS trimmed its position in shares of Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Free Report) by 25.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 74,251 shares of the company’s stock after selling 25,000 shares during the period. […]
Verrica Pharmaceuticals (NASDAQ:VRCA) Receives Buy Rating from Needham & Company LLC themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Shares of Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Get Free Report) dropped 3.5% during trading on Wednesday . The company traded as low as $5.10 and last traded at $5.17. Approximately 122,863 shares traded hands during mid-day trading, a decline of 37% from the average daily volume of 195,945 shares. The stock had previously closed at […]
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Short Interest Update theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Get Free Report) major shareholder Perceptive Advisors Llc bought 500,000 shares of the firm’s stock in a transaction on Friday, December 15th. The stock was purchased at an average cost of $5.97 per share, for a total transaction of $2,985,000.00. Following the completion of the acquisition, the insider now owns […]
Jefferies Financial Group reaffirmed their buy rating on shares of Verrica Pharmaceuticals (NASDAQ:VRCA – Free Report) in a report issued on Friday morning, Benzinga reports. Jefferies Financial Group currently has a $10.00 price objective on the stock. Several other equities analysts have also recently issued reports on the company. Needham & Company LLC reduced their […]
Needham & Company LLC reiterated their buy rating on shares of Verrica Pharmaceuticals (NASDAQ:VRCA – Free Report) in a report released on Thursday morning, Benzinga reports. They currently have a $10.00 price objective on the stock. A number of other research firms also recently commented on VRCA. Royal Bank of Canada raised their target price […]